The CD56+:CD3+ ratio was significantly lower in the GVHD group (mean ± SD: 5.5 ± 2.2%) than in the group with nonspecific or no inflammation (28.4 ± 16.3%, P = .006). The gene discussed is NCAM1; the disease is graft versus host disease.